chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore body; fever of 100; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. This 41-Year-old female Other HCP reported that:  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), via an unspecified route of administration administered in arm left, administration date 26Oct2021 11:15 (Batch/Lot number: unknown) at the age of 41 years as dose 3 (booster), single for covid-19 immunisation. facility type vaccine: Workplace clinic. Relevant medical history included: "Dermatomyositis" (unspecified if ongoing), notes: Verbatim: Dermatomyositis. The patient's concomitant medications were not reported. If other vaccine in four weeks: No, other medications in two weeks: None. Past drug history included: None. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Don't have card on me), when the patient was 41 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Don't have card on me, Location of injection: Arm Left), when the patient was 41 years old, for COVID-19 immunization. The following information was reported: PAIN with onset 27Oct2021 01:00, outcome "recovering", described as "Sore body"; PYREXIA with onset 27Oct2021 01:00, outcome "recovering", described as "fever of 100". Relevant laboratory tests and procedures are available in the appropriate section which included; Body temperature; 100 on 27Oct2021. Therapeutic measures were not taken as a result of pain.  Additional information: Most recent dose details: product; COVID 19, brand; Pfizer, brand unknown; False, lot unknown; True, lot unknown reason; Other, lot unknown reason other; Left vaccine card at my Pfizer office, administration date=26Oct2021, administration time; 11:15 AM, dose number; 3, vaccine location; Left arm.  Previous dose details: prev dose product; COVID 19, prev dose brand=Pfizer, prev dose brand unknown; False, prev dose lot unknown; True, prev dose lot unknown reason; Other, prev dose lot unknown reason other; Don't have card on me, prev dose dose number; 2, prev dose product; COVID 19, prev dose brand; Pfizer, prev dose brand unknown=False, prev dose lot unknown; True, prev dose lot unknown reason; Other, prev dose lot unknown reason other; Don't have card on me, prev dose dose number; 1, prev dose vaccine location; Left arm  Other vaccine same date details: other vaccine same date product; Pfizer, other vaccine same date vaccine date; 26Oct2021, other vaccine same date vaccine location; Left arm  Adverse event: Sore body, fever of 100, adverse event start date: 27Oct2021, adverse event start time: 01:00 AM, adverse event country: ae resulted in: None of the above, if patient recovered :Recovering, if treatment ae: No, if covid prior vaccination: No.  If covid tested post vaccination: No, known allergies: None, other medical history: Dermatomyositis.  The lot/batch number is not available despite the follow-up attempts made.  Follow-up attempts completed. No further information is expected.
Fractured ribs; break out on heel mostly on right foot/cracking bleeding; Arm discomfort; itchiness on palms; Fall; Skin fissure; This spontaneous case was reported by a consumer and describes the occurrence of RIB FRACTURE (Fractured ribs), SKIN HAEMORRHAGE (break out on heel mostly on right foot/cracking bleeding), LIMB DISCOMFORT (Arm discomfort), PRURITUS (itchiness on palms) and FALL (Fall) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced RIB FRACTURE (Fractured ribs), SKIN HAEMORRHAGE (break out on heel mostly on right foot/cracking bleeding), LIMB DISCOMFORT (Arm discomfort), PRURITUS (itchiness on palms), FALL (Fall) and SKIN FISSURES (Skin fissure). At the time of the report, RIB FRACTURE (Fractured ribs) was resolving and SKIN HAEMORRHAGE (break out on heel mostly on right foot/cracking bleeding), LIMB DISCOMFORT (Arm discomfort), PRURITUS (itchiness on palms), FALL (Fall) and SKIN FISSURES (Skin fissure) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.  She had fractured rib due to fall in shower. She was wrapped with bandage at doctor's office. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Treatment drug was not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
No additional adverse events reported; expired dose of GARDASIL 9 was administered to a patient on 09Mar2023; This spontaneous report was received from a registered nurse and refers to a patient of an unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history was not provided.  On 09-MAR-2023, the patient was vaccinated with an expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot #T028583, expiration date: 04-MAR-2023 (administration site, and route of administration were not provided) administered for prophylaxis (expired product administered). The reporter confirmed  that the dose was stored properly up through the time of administration. No additional adverse events were reported (no adverse event).
05/29/04 Left shoulder pain Left wrist swollen with pain with blister rash c/o itchy and hurt. 6/5/04 c/o rash Left shoulder decrease upper Left arm and wrist. Dx. shingles
local erythema, tenderness & swelling;discomfort down arm & wptoward neck
Syncope after receiving flushot X2 pt was fasting for labs he got the flu shot prior to completing his labs.
On the way home I had a taste of blood in my mouth. Every day I've had problems since the vaccine. I had a sharp pain in my left kidney and eye. I've had light headedness, dizziness, nausea. I've also had itchy ears. The site of the vaccine was hot to the touch and the heat and pain traveled down my left arm. At that point I called the doctor and it ended up that I had an infection. I eventually began to have warmth, tingling and pain throughout the left side of my face and the entire left side of my body with chills that occurred off and on. Every time I thought it was getting better, things would flare up again. Eventually, it went away but because I was having such difficulty I was calling my doctor every day for advice on whether or not I should get the second dose of the vaccine. When I went to get my second shot, the person I believe to be the pharmacist was hesitant to give me a dose of any vaccine even though my doctor advised that I receive the Pfizer vaccine rather than Moderna. She stated that with all of the issues I've had, that she did not believe I should get a second shot.
Painful Sores and/or blisters on lips and in mouth beginning around 48 hours post vaccine. Had 1 blister on lip yesterday, now have 5 including inside of mouth and roof of mouth.
A few days after receiving my first Pfizer Covid vaccine I started experiencing frequent headaches I have now had a headache almost 10 days. A dull ache headache. That wakes up at night and come and go all day long.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 08:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraines and headaches which was ongoing from an unknown date. The patient was allergic to dairy and its proteins, almonds and mushrooms. Concomitant medications included verapamil (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), vitamin D nos (MANUFACTURER UNKNOWN) and Tur ; all from an unknown date, for an unknown indication, unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, at 12:00 the patient experienced frequent headaches and had a headache almost 10 days The patient reported a dull ache headache that woke her up at night and come and went all day long. The patient was suffering from chronic migraines but reported that this was different. and she used to take Botox for her headaches every three months. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event frequent headaches was not recovered at the time of this report.   No follow-up attempts are required; information about lot number cannot be obtained. No further information is expected.
Moderna COVID vaccine Lot#004M20A-2nd dose administered.  At 9 hours I developed moderate chills and shaking with teeth chattering lasting 1.5 hours with full recovery.  Myalgias persist into second day.
Shingles Virus rash on right side below belt loop/ waistline, Also, rash on right leg below calf muscle area. Treatment: began 05/30/2015 evening by taking anti-viral Valacyclovir medication prescribed for three times daily for one week.
On 10/12/2000 the patient developed a 2 cm indurated, four 6 mm warm clear vesicles at the injection site. The patient developed six 4mm red vesicles at the edge of the patient's lip. Subsequently, the patient was diagnosed with cellulitis secondary to the varicella virus vaccine live. The NP reported that on 10/19/2000, the patient recovered from the cellulitis. Unspecified medical attention was sought. Additional information has been requested.
Pt was given 4 vaccinations, Pt was seated after all were given pt laid his head down on his arm, This RN shook pt and said his name and he did not respond for 10 seconds. He responded after 10 seconds and was pale + Nauseous. Squad was called to evaluate. Left Health Dept with mother not squad. Was not taken to hospital.
Vomiting all morning. Chills then vomit, then break out in a sweat, mild headache. Low fever at 100 degrees. Haven?t been able to keep any liquids down for 7 hours.
I had lower back pain and some abdomen pain in the early morning 09/30/2022. I went to my doctor on 10/04/2022 due to the pain I had an x-ray and urine test on 10/04/2022 the urine came back normal, and the x-ray of my back did show slight narrow spacing in the lower spine. The pain did cause me to miss work on Monday and Tuesday. My doctor gave me a prescription of FLEXERIL and lidocaine patches for my back. As of today, I am feeling much better than I have been, but I am unsure if that is because I am on medication or if it is getting better.
I have a constant pain in my ears that doesn't go away since my vaccines, I don't hear good. My conscious is very low.
Information has been received from an office manager, also reported as a healthcare worker, concerning a currently 4 year old female patient who was vaccinated with her first dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live before 12 months of age. Therefore, as second dose was given at 20 months of age. On 13OCT2003 it was reported that one month ago the patient was vaccinated with a third dose of measles virus vaccine live + mumps vaccine live + rubella virus vaccine live. Concomitant therapy included vaccination with several other vaccines, not specified, on the same day as vaccination with the third dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live . within 24 hours of the third dose of vaccination the patient developed a rash. Unspecified medical attention was sought. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to an unspecified number patients of unknown age and gender. There was no information regarding the patients' medical history, concomitant medications, drug reactions or allergies provided. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # N010107, expiration date: 18-MAR-20119, for prophylaxis. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT). The vaccines were stored in temperature from 15 degrees Fahrenheit to 46 degrees Fahrenheit for 26 hours and 15 minutes. There was no previous temperature excursion. The call was because of digital data logger. No product quality complaint was involved.
high pitch cry, irritable, movement of eyes/extremities 1hr p/vax given;crying for 24hr, seen in office-turned off lights, APAP
injection site redness; Fever; chills; This is a spontaneous report from a contactable other healthcare professional (HCP). This Other HCP reported similar events for 2 patients on behalf of physician. This is 2nd of two reports.   A 15-year-old female patient started to receive meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on 25Apr2019 at a single dose for immunisation. The patient's medical history concomitant medications were not reported. The patient experienced fever, chills, and injection site redness on an unspecified date. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019337069 same reporter/drug different patients with similar events
Within 1 hour on 9-12-17 when the vaccine was given the patient had a bruise about 1 inch wide. Today 9-16-17 the patients arm looked bruised with a diameter of 3-4 inches and red around the injection site.
Chills, fever of 100.2 degrees - 100.4 degrees.; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Chills, fever of 100.2 degrees - 100.4 degrees.) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (Chills, fever of 100.2 degrees - 100.4 degrees.) and CHILLS (Chills). At the time of the report, PYREXIA (Chills, fever of 100.2 degrees - 100.4 degrees.) and CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Patient is 16 years of age and received Moderna COVID-19 vaccine.  No adverse event at this time.
Severe headache started the morning of 10/16/13. Allergic reaction on arm of injection site - red, hot, swollen and itchy. Saw my physician on 10/17/13. Was given prescription VALTREX 500mg 2 tabs now and 2 table 12 hrs. Start ADVIL 200mg 1 tab.
Ringing in the ears since March 1, 2021. Referred to an Otolaryngologist.
Fever, turgor, erythema, and tenderness. Rx: BACTRIM 200/40/5mL, Triamcinolone topical 0.1%; ORAPRED 15 mg/5mL, MOTRIN.
I had unusual spotting. I had been in menopause for three years. I felt like it was a period cramping and emotional the day before. Very light spotting for five days. I called my doctor immediately. Note: Shingles vaccines were taken at February 26th, 2021 (second) 1st one in November 2020; either the 4th or the 20th.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 27-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 02-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. No treatment given to patients.
Reddness occurred recently, both arms; hard lump at the injection site; Severe right shoulder joint pain; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP7534) via an unspecified route of administration, administered in left arm on 18Mar2021 at 10:15 (at the age of 76 years) as single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included Amlodipine/Valsartan 5/160mg Tab, Finasteride 5mg. Patient was not aware of allergies. The patient previously had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number:EN6205) via an unspecified route of administration, administered in right arm on an unspecified date in Feb2021 as single dose for COVID-19 immunisation and experienced swelling, redness, hard lump and a small blister. Patient was not diagnosed with COVID-19 prior the vaccination. The patient received no other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021, reddness occurred recently both arms, had a hard lump at the injection site and severe right shoulder joint pain. The patient did not receive treatment for events. Patient was not tested for COVID-19 since the vaccination. The outcome of the events was not recovered.  No follow up attempts are needed. No further information is expected.
got the flu shot many times sometimes with or without the shot I get the flu; Initial information received on 14-Dec-2020 regarding an unsolicited valid non-serious case was received from a consumer (patient) via social media.  This case involves an unknown age patient who got Influenza (got the flu shot many times sometimes with or without the shot I get the flu), while he/she received vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza Vaccine produced by unknown manufacturer lot number not reported via unknown route in unknown administration site, for Prophylactic vaccination.  On an unknown date, it was reported that the patient reported that he/she got the flu shot many times sometimes with or without the shot he/she got the flu (Influenza) (Unknown latency) following the administration of Influenza Vaccine.   No laboratory data was reported.  Action taken was not applicable. It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown.  No further information was reported.
patient had fever when he got his 1st - dose of Shingrix; This case was reported by a consumer via call center representative and described the occurrence of fever in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The case was reported by the wife of the patient. The age at vaccination was not reported. The patient had fever when he got his 1st of Shingrix in right arm. The reporter consented to follow up. For tolerance to 2nd dose refer linked case US2020176123, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020176123:same patient
Patient complained (L) arm hurt right after HPV injection at (L) upper arm. She can not fully lift her left arm next day. She presented (L) leg hurt and limping 2nd days after injection.
arm swelling; Bump the size of a tennis ball; discomfort in the arm that received the injection; This spontaneous report has been received from pharmacist concerning a 64-year-old female patient. Her concurrent conditions, medical history, drug reactions/allergies, and concomitant medications were not provided.  On 23-AUG-2022, the patient was vaccinated with a dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe 0.5 ml/once, administered as prophylaxis, lot number U027357, expiration date 25-MAR-2023, route of administration was reported as "injection".  On the same date, the patient experienced arm swelling (Vaccination site swelling), a bump the size of a tennis ball (Vaccination site mass), and discomfort in the arm that received the injection (Vaccination site discomfort) which was all referred by the patient through a call to the provider's office on 25-AUG-2022, seeking for medical attention. The patient was advised to use warm compress and to take ibuprofen as needed. At the time of the report, she had not recovered from the events.    The Causal relationship between Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) and all reported events was unknown.
CMA, administered a pediatrics pfizer covid vaccine without diluting to patient.  Provider contacted patient's parent. Parent said patient is okay, sore but will continue to monitor.
Cellulitis; head feels mentally in the fog; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (Cellulitis) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    The patient's past medical history included Cellulitis and Foggy feeling in head.  On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced CELLULITIS (Cellulitis) (seriousness criterion medically significant) and FEELING ABNORMAL (head feels mentally in the fog). At the time of the report, CELLULITIS (Cellulitis) and FEELING ABNORMAL (head feels mentally in the fog) outcome was unknown.            Concomitant product use was not provided by the reporter. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Patient had a huge rash and doctor diagnosed it as cellulitis which itched, burned and felt kind of achy. The same thing happened with flu shot. This case was linked to MOD-2021-086069 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.